Skip to main content
. Author manuscript; available in PMC: 2015 Apr 30.
Published in final edited form as: J Hematop. 2013 Mar;6(1):11–18. doi: 10.1007/s12308-012-0166-4

Fig. 2.

Fig. 2

a Kaplan–Meier plot of survival (time period from the diagnosis to the endpoint) for low expression (gray line) and overexpression (black line) of FASN (p=0.002, HR=2.92, 95 % CI 1.180–5.803). b Kaplan–Meier plot of progression-free survival for low expression and overexpression of FASN (p=0.004, HR=3.96, 95 % CI 1.547–10.45). Notch denotes the censored data